---
title: "T细胞耗竭的关键细胞因子"
date: 2025-08-22T03:48:21Z
draft: ["false"]
tags: [
  "fetched",
  "闲谈 Immunology"
]
categories: ["Acdemic"]
---
T细胞耗竭的关键细胞因子 by 闲谈 Immunology
------
<div><p data-pm-slice="2 2 []"><span leaf=""><span textstyle="">T 细胞耗竭（T cell exhaustion）是慢性感染、癌症等疾病中 T 细胞功能逐渐丧失的状态，其发生与多种细胞因子的调控密切相关。这些细胞因子通过影响 T 细胞的增殖、分化、存活及功能发挥，参与耗竭过程的启动、维持或逆转。</span></span></p><h3><strong><span leaf=""><span textstyle="">促进 T 细胞耗竭的细胞因子</span></span></strong></h3><ol><li><p><strong><span leaf=""><span textstyle="">IL-10</span></span></strong></p></li></ol><ul><li><strong><span leaf=""><span textstyle="">作用</span></span></strong><section><span leaf=""><span textstyle="">IL-10 是典型的免疫抑制性细胞因子，可直接抑制 T 细胞的增殖和细胞因子（如 IFN-γ、TNF-α）的产生，促进耗竭表型（如 PD-1、Tim-3 高表达）的维持。</span></span></section></li><li><strong><span leaf=""><span textstyle="">机制</span></span></strong><section><span leaf=""><span textstyle="">通过激活 T 细胞内的 STAT3 信号通路，抑制促炎基因表达，同时增强免疫检查点分子的转录。</span></span></section></li><li><strong><span leaf=""><span textstyle="">相关疾病</span></span></strong><section><span leaf=""><span textstyle="">慢性 HBV/HCV 感染、肿瘤微环境中 IL-10 水平升高，与 T 细胞耗竭程度正相关。</span></span></section></li></ul><li><p><strong><span leaf=""><span textstyle="">TGF-β</span></span></strong></p></li><ul><li><strong><span leaf=""><span textstyle="">作用</span></span></strong><section><span leaf=""><span textstyle="">TGF-β 可抑制 T 细胞的活化和效应功能，诱导耗竭相关转录因子（如 TOX）的表达，同时促进调节性 T 细胞（Treg）的分化，间接加剧 T 细胞耗竭。</span></span></section></li><li><strong><span leaf=""><span textstyle="">机制</span></span></strong><section><span leaf=""><span textstyle="">通过 SMAD 通路抑制 T 细胞受体（TCR）信号传导，降低 T 细胞对肿瘤或病毒抗原的敏感性。</span></span></section></li><li><strong><span leaf=""><span textstyle="">相关疾病</span></span></strong><section><span leaf=""><span textstyle="">实体瘤（如黑色素瘤、肝癌）、慢性寄生虫感染中 TGF-β 高表达，与 T 细胞功能受损密切相关。</span></span></section></li></ul><li><p><strong><span leaf=""><span textstyle="">IL-23</span></span></strong></p></li><ul><li><strong><span leaf=""><span textstyle="">作用</span></span></strong><section><span leaf=""><span textstyle="">IL-23 主要由髓系细胞分泌，可通过促进 Th17 细胞分化间接抑制细胞毒性 T 细胞（CD8⁺ T）功能，同时增强炎症微环境中的免疫抑制信号，加速 T 细胞耗竭。</span></span></section></li><li><strong><span leaf=""><span textstyle="">机制</span></span></strong><section><span leaf=""><span textstyle="">激活 STAT3 和 NF-κB 通路，上调 IL-17 等促炎因子，导致 T 细胞所处微环境失衡。</span></span></section></li><li><strong><span leaf=""><span textstyle="">相关疾病</span></span></strong><section><span leaf=""><span textstyle="">慢性炎症性疾病（如结肠炎）、部分肿瘤中 IL-23 水平与 T 细胞耗竭标志物（如 PD-1）共表达。</span></span></section></li></ul><h3><strong><span leaf=""><span textstyle="">逆转或缓解 T 细胞耗竭的细胞因子</span></span></strong></h3><ol><li><p><strong><span leaf=""><span textstyle="">IL-2</span></span></strong></p></li></ol><ul><li><strong><span leaf=""><span textstyle="">作用</span></span></strong><section><span leaf=""><span textstyle="">低剂量 IL-2 可促进 T 细胞增殖和存活，维持效应功能，减少耗竭标志物（如 PD-1）的表达；但高剂量可能诱导 Treg 扩增，需精准调控。</span></span></section></li><li><strong><span leaf=""><span textstyle="">机制</span></span></strong><section><span leaf=""><span textstyle="">激活 STAT5 通路，增强抗凋亡基因（如 Bcl-2）的表达，维持 T 细胞的代谢活性。</span></span></section></li><li><strong><span leaf=""><span textstyle="">应用</span></span></strong><section><span leaf=""><span textstyle="">在肿瘤免疫治疗中，IL-2 与免疫检查点抑制剂联合使用可增强 T 细胞的抗肿瘤活性。</span></span></section><section nodeleaf=""><img data-src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicTFtsdnXTW25LgqcNqkDPzYmkJN8VJl4ics1lLKtlRguQib8pTbV3MPbIaOJbV6wHDicpUPS9ralMgaQ/640?wx_fmt=png&amp;from=appmsg" data-ratio="0.9616336633663366" data-s="300,640" data-type="png" data-w="808" type="block" data-imgfileid="100043992" src="https://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicTFtsdnXTW25LgqcNqkDPzYmkJN8VJl4ics1lLKtlRguQib8pTbV3MPbIaOJbV6wHDicpUPS9ralMgaQ/640?wx_fmt=png&amp;from=appmsg"></section></li></ul><li><p><strong><span leaf=""><span textstyle="">IL-12</span></span></strong></p></li><ul><li><strong><span leaf=""><span textstyle="">作用</span></span></strong><section><span leaf=""><span textstyle="">IL-12 可促进 CD8⁺ T 细胞向效应细胞分化，增强 IFN-γ 的分泌，逆转部分耗竭表型，尤其在慢性感染早期可延缓耗竭进程。</span></span></section></li><li><strong><span leaf=""><span textstyle="">机制</span></span></strong><section><span leaf=""><span textstyle="">通过 STAT4 通路激活 T-bet 等转录因子，维持 T 细胞的细胞毒性功能。</span></span></section></li><li><strong><span leaf=""><span textstyle="">研究证据</span></span></strong><section><span leaf=""><span textstyle="">在慢性 HBV 感染模型中，IL-12 可协同 CD4⁺ T 细胞帮助 CD8⁺ T 细胞恢复功能（如本文献中提到 IL-12 可扩增 CD4⁺ T 细胞池，间接支持 CD8⁺ T 细胞活化）。</span></span></section></li></ul><li><p><strong><span leaf=""><span textstyle="">IL-27</span></span></strong></p></li><ul><li><strong><span leaf=""><span textstyle="">作用</span></span></strong><section><span leaf=""><span textstyle="">IL-27 是近年来备受关注的 “双重功能” 细胞因子，在慢性感染中可逆转 T 细胞耗竭，促进效应功能恢复，同时抑制过度炎症。</span></span></section></li><li><strong><span leaf=""><span textstyle="">机制</span></span></strong><section><span leaf=""><span textstyle="">激活 STAT1 和 STAT3 通路，上调 Sca-1 等活化标志物，减少 PD-1 等抑制分子的表达，直接增强 CD8⁺ T 细胞的抗病毒或抗肿瘤活性。</span></span></section></li><li><strong><span leaf=""><span textstyle="">研究证据</span></span></strong><section><span leaf=""><span textstyle="">本文献明确指出，IL-27 是逆转 HBV 诱导的 CD8⁺ T 细胞耗竭的关键因子，外源性 IL-27 可恢复慢性 HBV 患者 T 细胞的功能。</span></span></section></li></ul><li><p><strong><span leaf=""><span textstyle="">IFN-γ</span></span></strong></p></li><ul><li><strong><span leaf=""><span textstyle="">作用</span></span></strong><section><span leaf=""><span textstyle="">IFN-γ 是 CD8⁺ T 细胞的主要效应细胞因子，同时可通过增强抗原呈递细胞（如树突状细胞）的功能，间接促进 T 细胞活化，缓解耗竭。</span></span></section></li><li><strong><span leaf=""><span textstyle="">机制</span></span></strong><section><span leaf=""><span textstyle="">上调 MHC-I 类分子和共刺激分子（如 CD80/CD86）的表达，优化 T 细胞与抗原呈递细胞的相互作用。</span></span></section></li><li><strong><span leaf=""><span textstyle="">注意</span></span></strong><section><span leaf=""><span textstyle="">慢性疾病中 IFN-γ 分泌常减少，其水平降低是 T 细胞耗竭的重要标志之一。</span></span></section></li></ul><h3><strong><span leaf=""><span textstyle="">细胞因子网络与 T 细胞耗竭的调控</span></span></strong></h3><p><span leaf=""><span textstyle="">T 细胞耗竭并非由单一细胞因子决定，而是多种因子构成的网络共同作用的结果。例如：抑制性因子（IL-10、TGF-β） 与 刺激性因子（IL-2、IL-12、IL-27） 的平衡决定 T 细胞的功能状态；免疫检查点分子（PD-1/PD-L1、CTLA-4）与细胞因子信号通路存在交叉调控（如 IL-10 可上调 PD-L1 表达）。</span></span></p><section><span leaf=""><span textstyle="">参考资料</span></span></section><p data-pm-slice="0 0 []"><span lang="EN-US"><span leaf=""><span textstyle="">Interleukin-10 in cancer immunotherapy from bench to bedside</span></span></span><span leaf=""><span textstyle="">，</span></span><span lang="EN-US"><span leaf=""><span textstyle="">Trends Cancer. 2023 September ; 9(9): 716–725. doi:10.1016/j.trecan.2023.05.003</span></span><p></p></span></p><p><span lang="EN-US"><span leaf=""><span textstyle="">IL-2 signaling strength dictates T cell biology and therapeutic outcomes in autoimmunity and cancer</span></span></span><span leaf=""><span textstyle="">，</span></span><span lang="EN-US"><span leaf=""><span textstyle="">Immunity. 2024 March 12; 57(3): 414–428. doi:10.1016/j.immuni.2024.02.001.</span></span><p></p></span></p><p data-pm-slice="0 0 []"><span lang="EN-US"><span leaf=""><span textstyle="">Cytokine storm promoting T cell exhaustion in severe COVID-19 revealed by single cell sequencing data analysis</span></span></span><span leaf=""><span textstyle="">，</span></span><span lang="EN-US"><span leaf=""><span textstyle="">Precision Clinical Medicine, 2022, 5: pbac014 DOI: 10.1093/pcmedi/pbac014</span></span></span></p><section nodeleaf=""><mp-common-profile data-pluginname="mpprofile" data-nickname="闲谈 Immunology" data-alias="xiantanimmunology" data-from="0" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/h4TnoxFENicSUg9Zeq93L0JONScSZFlntu2ygj7iaq0trvU3x8sot8hpJ5U6PmtPsys5kiaqkTv364qWAdIQgqoSQ/0?wx_fmt=png" data-signature="专注ImmunoBiology，桥接基础研究与产业应用！" data-id="Mzg2OTczNjI0OQ==" data-is_biz_ban="0" data-service_type="1" data-verify_status="2"></mp-common-profile></section><p><mp-style-type data-value="3"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/XELbS-UDz7MEZosuA791Zw",target="_blank" rel="noopener noreferrer">原文链接</a>
